DeepMed Research

Indiana University Foundation, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1820-01-20

Employees: 10K

Market Cap: -

Website: http://www.indiana.edu

Clinical Trials

Clinical Impact of EUS in Staging NSCLC

Completed

Conditions: Non Small Cell Lung

First Posted Date: 2007-12-20

Last Posted Date: 2014-09-05

Lead Sponsor: Indiana University

Target Recruit Count: 110

Registration Number: NCT00577746

Locations: 🇺🇸
Indiana University Medical Center; Clarian Health, Indianapolis, Indiana, United States

Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer

Phase 2

Completed

Conditions: Stage IV Breast Cancer
Progesterone Receptor-negative Breast Cancer
Estrogen Receptor-negative Breast Cancer
Recurrent Breast Cancer

Interventions: Drug: Medroxyprogesterone progesterone acetate (MPA)
Drug: Medroxyprogesterone with Cyclophosphamide + Methotrexate

First Posted Date: 2007-12-19

Last Posted Date: 2023-10-16

Lead Sponsor: Indiana University

Target Recruit Count: 30

Registration Number: NCT00577122

Locations: 🇺🇸
Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Duke University Comprehensive Cancer Center, Durham, North Carolina, United States

and more 4 locations

Cap-fitted Colonoscopy: a Randomized, Tandem Colonoscopy Study of Adenoma Miss Rates

Not Applicable

Completed

Conditions: Polyps

Interventions: Device: Cap-fitted colonoscopy

First Posted Date: 2007-12-19

Last Posted Date: 2018-12-10

Lead Sponsor: Indiana University

Target Recruit Count: 100

Registration Number: NCT00577083

Locations: 🇺🇸
Indiana University Medical Center, Indianapolis, Indiana, United States

Exercise-based Motivational Interviewing for Fibromyalgia

Not Applicable

Completed

Conditions: Fibromyalgia

Interventions: Behavioral: Attention Control Counseling
Behavioral: Motivational Interviewing

First Posted Date: 2007-12-14

Last Posted Date: 2012-04-06

Lead Sponsor: Indiana University

Target Recruit Count: 200

Registration Number: NCT00573612

Locations: 🇺🇸
National Institute of Fitness of Sports, IUPUI Campus, Indianapolis, Indiana, United States

Can CT Enteroclysis Predict the Outcome of Crohn's Disease

Completed

Conditions: Crohn's Disease

First Posted Date: 2007-12-13

Last Posted Date: 2015-08-10

Lead Sponsor: Indiana University

Target Recruit Count: 125

Registration Number: NCT00572780

Locations: 🇺🇸
Indiana University, Indianapolis, Indiana, United States

Gastric Pacemaker Implantation for Gastroparesis

Not Applicable

Withdrawn

Conditions: Gastroparesis

Interventions: Device: Enterra Gastric Pacemaker

First Posted Date: 2007-12-06

Last Posted Date: 2021-03-05

Lead Sponsor: Indiana University

Registration Number: NCT00568373

Study to Evaluate the Effectiveness of Certain Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants During Pregnancy and Evaluate Newborn Outcomes

Terminated

Conditions: Depression

First Posted Date: 2007-11-06

Last Posted Date: 2024-04-02

Lead Sponsor: Indiana University

Target Recruit Count: 18

Registration Number: NCT00553917

Locations: 🇺🇸
IUPUI, Indianapolis, Indiana, United States

Metabolomics-Based Detection of Colorectal Cancer

Completed

Conditions: Colorectal Cancer

First Posted Date: 2007-07-26

Last Posted Date: 2014-09-11

Lead Sponsor: Indiana University

Target Recruit Count: 69

Registration Number: NCT00507598

Locations: 🇺🇸
Indiana University Cancer Center, Indianapolis, Indiana, United States

Healozone Study to Evaluate the Safety and Efficacy of the Use of Ozone for Management of Dental Caries

Phase 2

Completed

Conditions: Dental Caries

Interventions: Device: Ozone treatment
Device: Placebo treatment

First Posted Date: 2007-07-03

Last Posted Date: 2015-02-20

Lead Sponsor: Indiana University

Target Recruit Count: 394

Registration Number: NCT00495495

Locations: 🇺🇸
Indiana University School of Dentistry, Indianapolis, Indiana, United States
🇺🇸
State University of New York at Buffalo, School of Dental Medicine, Buffalo, New York, United States
🇺🇸
Tufts University School of Dental Medicine, Boston, Massachusetts, United States

Trial of Decitabine as a Sensitizer to Carboplatin in Platinum Resistant Recurrent Ovarian Cancer

Phase 1

Completed

Conditions: Ovarian Cancer

Interventions: Drug: decitabine

First Posted Date: 2007-05-23

Last Posted Date: 2014-09-25

Lead Sponsor: Indiana University

Target Recruit Count: 28

Registration Number: NCT00477386

Locations: 🇺🇸
Indiana University Cancer Center, Indianapolis, Indiana, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy